The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Share News (HCM)

Share Price Information for Hutchmed (HCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 304.00
Bid: 303.00
Ask: 307.00
Change: 8.00 (2.70%)
Spread: 4.00 (1.32%)
Open: 306.00
High: 310.00
Low: 300.00
Prev. Close: 304.00
HCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: STV looks to summer's football; In The Style sales up

Thu, 29th Apr 2021 14:34

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

STV Group PLC - Glasgow-based television broadcaster - Says recovery of advertising revenue exceeds expectations, running 10% ahead of forecasts. "STV-controlled advertising continues to outperform the wider market, with regional advertising revenues up 12% in the first four months of the year," company adds. Video on demand service advertising also grew, up 26% annually and posts eight successive months of growth. Online viewing grew 73% in first quarter. Expects viewing figures in June as delayed Euro 2020 football championships kick off.

----------

In The Style Group PLC - e-commerce womenswear fashion brand - Says sales momentum since March float top expectations. Revenue for year ended March 31 to soar to GBP44.5 million from GBP19.3 million. "In light of the strong trading performance, prior to the year end the group returned financial support previously claimed under the Coronavirus Job Retention Scheme," company adds.

----------

Inspecs Group PLC - eyewear design house and manufacturer based in Bath - Says first quarter revenue amounted to USD67 million. "This performance was achieved despite nationwide lockdowns in the UK, Germany and France and a variety of state lockdowns in the USA," Inspecs says. "Whilst this performance marks a positive start to the year, the board remains cautious on 2021 as Covid-19 remains prevalent across the world."

----------

Appreciate Group PLC - Liverpool-based multi-retailer - Pretax profit for year ended March 31 in line with market expectations range of GBP4.1 million an GBP4.8 million. Group billings down 3.2% to GBP406.5 million from GBP419.9 million.

----------

City Pub Group PLC - operates 48 pubs in southern England and Wales - Acquires 49% stake in Barts Pub Ltd, owner of Kensington Park Hotel in London's Ladbroke Grove, for GBP750,000. "It has large trading areas on the ground and first floors, benefits from seven hotel letting rooms and has potential for a further four letting rooms on the top floor. Ladbroke Grove is a prime residential area in London and the Company trades very successfully at the Cock & Bottle, Notting Hill, which is located close by," City Pub says. Increases stake in Mosaic Pub & Dining Group to 24% for GBP1.2 million. "The company acquired a 14% stake in the Mosaic Companies in September 2020 and this transaction takes its total investment to GBP2.4 million," company adds. Mosaic owns nine "prominent pubs" and largely operates in London and Birmingham.

----------

Arricano Real Estate PLC - developer and shopping mall operator in Ukraine - In separate announcements notes the easing of restrictions in Ukraine and an altered loan facility in country. Says Kiev retail shopping centres to reopen on May 1 but says its City Mall in Zaporizhzhia closed until further notice. Also says unit LLC Comfort Market Luks alters debt arrangement with State Savings Bank of Ukraine. Debt now carries 6.5% annual interest, down from 7.5%.

-----------

Symphony International Holdings Ltd - Hong Kong-based investor - Asset Value Investors, which holds 15% stake in Symphony, takes aim at management of investment firm. Pens note to shareholders labelled "Save Symphony". "The poor performance of Symphony International Holdings Ltd has gone on long enough. We have two key aims and we need the support of our fellow shareholders to make them a reality," Asset Value Executive Director Tom Treanor says. Company wants to gather enough support to requisition extraordinary general meeting to replace directors. Also wants all shareholders to be "fully informed as to our concerns regarding the stewardship of SIHL and the independence of the board".

----------

LMS Capital PLC - London-based investment firm - Net asset value at end of first quarter slips 0.8% to 58.9 pence per share from 59.4p at end of December. Sees GBP300,000 unrealised gains on investment portfolio, but GBP200,000 million foreign exchange hit and GBP500,000 of running and investment costs.

----------

FastForward Innovations Ltd - investor in life sciences and technology businesses particularly within the medical cannabis field - Says 5.1%-owned Yooma Wellness Inc's CBD food products from its MYO Plant Nutrition and Blossom brands added to UK Food Standard Agency's novel foods list. "This approval represents a significant milestone for the MYO and Blossom brands," Yooma Chair Lorne Abony says.

----------

Hutchison China Meditech Ltd - Hong-Kong-based pharmaceutical company - Initiates registration-intent Phase II clinical trial of HMPL‑689, a PI3Ko inhibitor and can be used to treat forms of cancer. Trial focused on patients with relapsed or refractory follicular lymphoma and marginal zone lymphoma. On Wednesday, shareholders backed company's name change to Hutchmed (China) Ltd. Name change effective only Registrar of Companies issues certificate.

----------

Verici Dx PLC - clinical diagnostics developer for organ transplant - Signs lease in Tennessee, US for site it plans to use as Clinical Laboratory Improvement Amendments-certified laboratory. "I joined the company in January this year to help expedite the CLIA approval strategy and signing the lease to this space marks the first step towards achieving these CLIA approvals necessary for commercial launch of the company's leading products, Clarava and Tuteva," Vice President of Quality & Regulatory Affairs David Schultenover says.

----------

InnovaDerma PLC - London-based developer of beauty, personal care and life science products - Raises GBP500,000 from open offer, taking total fundraising to GBP4.5 million. Non-Executive Chair Ross Andrews says "macroeconomic environment is set to remain uncertain" this financial year but notes UK vaccinations and government lockdown easing roadmap going according to plan. "We've just entered the peak tanning season and the exact speed of a return to historical consumption levels will only be known over the coming months," Andrews adds.

----------

Yourgene Health PLC - Manchester, England-headquartered molecular diagnostics firm - Says revenue for year ended March 31 to rise 10% to GBP18.3 million from GBP16.6 million. "This is in line with recently issued guidance and reflects strong performances for European core revenues and for Covid-related testing products and services focused on the UK, more than offsetting the pandemic headwinds affecting international sales," Yourgene adds.

----------

Silence Therapeutics PLC - novel RNA therapeutics developer with offices in London and Berlin - Says first patient dosed in Gemini Phase I clinical trial of SLN124, a treatment for a rare pediatric disease. "Today's announcement is an exciting milestone in the development of SLN124. It is the result of many years of hard work," Chief Medical Officer Giles Campion says.

----------

Danakali Ltd - Colluli potash project developer - Raises AUD20.3 million, to fund work at Colluli asset, Eritrea. Says early works programme will begin "immediately".

----------

Greatland Gold PLC - precious and base metals exploration and development in Western Australia and Tasmania - Notes Newcrest Mining Ltd's quarterly update which refers to progress at Havieron gold asset. Says new assay results show four holes intersect "significant mineralisation". Results from wider growth drilling "continue to support the potential for resource expansion of the Havieron".

----------

Salt Lake Potash Ltd - Western Australia focused organic sulphate of potash miner - Receives new portion of environmental approval for Lake Way project. Says permit enables firm to construct pond trains 4-6. "Receiving final environmental approval over the full Lake Way project will enable our team to commence construction of the remaining on-lake infrastructure and deliver the full scope of the Lake Way project. We look forward to commencing work shortly on this final phase," Chief Executive Officer Tony Swiericzuk says.

----------

Ariana Resources PLC - exploration and development company operating in Europe - Reports promising findings from drilling results at Arzu North portion of Kiziltepe mine in Turkey. Says over 450 metres of "potentially open-pittable extensions confirmed". Adds that revised JORC exploration target now includes addition 7,000 ounces to 25,000 ounces of gold and 150,000 ounces to 250,000 ounces of silver, representing a more than four-fold resource hike. "This is an excellent set of results from the recent drilling at Arzu North. Collectively these results confirm the potential to extend the Arzu North open pit both to the northwest and to the southeast," Managing Director Kerim Sener says.

----------

Condor Gold PLC - gold exploration and development in Nicaragua - Says all infill drilling and assay at La India starter pits completed. "The drilling results received to date support, and add considerable confidence to, the geological model," Condor Gold says. Drilling underway for remaining 1,142 metres of work in La India open pit shell.

----------

Horizonte Minerals PLC - nickel company focused on Brazil - Hands environmental & social impact assessment at Vermelho nickel and cobalt project to consultancy firm Ramboll. "Ramboll's Impact Assessment services are based on both commercial understanding and technical rigour to deliver projects that are advanced, sustainable and provide value to society. Horizonte has previously worked with Ramboll on the hydrology for its flagship Araguaia ferronickel project," Horizonte adds.

----------

Gaming Realms PLC - London-based mobile games developer - Begins trading on OTCQX Best Market in US. "Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their US investors," company notes.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
5 Apr 2024 11:54

Hutchmed China to make several presentations at cancer research meeting

(Sharecast News) - Hutchmed China announced the upcoming presentation of new and updated data from various studies featuring compounds it had discovered on Friday, at the American Association of Cancer Research (AACR) annual meeting from 5 to 10 April in San Diego, California.

Read more
2 Apr 2024 12:11

Hutchmed endometrial cancer treatment gets priority review in China

(Sharecast News) - Hutchmed China announced the acceptance and granting of priority review by the China National Medical Products Administration (NMPA) for a new drug application combining fruquintinib and sintilimab for the treatment of advanced endometrial cancer on Tuesday.

Read more
2 Apr 2024 10:32

Hutchmed endometrial cancer treatment application accepted for review

(Alliance News) - Hutchmed (China) Ltd on Tuesday jointly announced with Innovent Biologics that their new drug application for the combined fruquintinib and sintilimab treatment for endometrial cancer has been granted priority review by the China National Medical Products Administration.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
28 Mar 2024 13:02

Hutchmed cancer treatment indication accepted for review in China

(Sharecast News) - Hutchmed China announced a significant milestone in its cancer treatment work on Thursday, with the supplemental new drug application (sNDA) for savolitinib had been accepted for review by the China National Medical Products Administration (NMPA).

Read more
28 Mar 2024 11:08

Hutchmed lung cancer treatment accepted for review in China

(Alliance News) - Hutchmed (China) Ltd on Thursday said its supplemental new drug application for savolitinib has been accepted for review by the China National Medical Products Administration.

Read more
28 Mar 2024 08:08

LONDON BRIEFING: JD Sports backs outlook; Spirent accepts new offer

(Alliance News) - Stocks in London traded higher early on Thursday in the final trading day of a holiday-shortened week, despite some hawkish words from a US central banker.

Read more
22 Mar 2024 10:09

Hutchmed begins registration stage for sovleplenib phase 2/3 trial

(Alliance News) - Hutchmed (China) Ltd on Friday said it initiated the registration stage of the phase 2/3 clinical trial for sovleplenib, its warm antibody autoimmune hemolytic anemia treatment.

Read more
28 Feb 2024 17:31

EARNINGS: Hutchmed revenue surges, Craven House's loss widens

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
21 Feb 2024 15:14

UK earnings, trading statements calendar - next 7 days

Thursday 22 February 
Anglo American PLCFull Year Results
Genus PLCHalf Year Results
Hargreaves Lansdown PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Indivior PLCFull Year Results
Jupiter Fund Management PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
ME Group International PLCFull Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
WPP PLCFull Year Results
Friday 23 February 
City of London Investment Group PLCHalf Year Results
Irish Residential Properties REIT PLCFull Year Results
Standard Chartered PLCFull Year Results
Monday 26 February 
Base Resources LtdHalf Year Results
Bunzl PLCFull Year Results
EnSilica PLCHalf Year Results
Kosmos Energy LtdFull Year Results
Made Tech Group PLCHalf Year Results
Tristel PLCHalf Year Results
Tuesday 27 February 
abrdn Equity Income Trust PLCFull Year Results
abrdn PLCFull Year Results
Croda International PLCFull Year Results
Kitwave Group PLCFull Year Results
McBride PLCHalf Year Results
PCI-PAL PLCHalf Year Results
Smith & Nephew PLCFull Year Results
Synectics PLCFull Year Results
Uniphar PLCFull Year Results
Unite Group PLCFull Year Results
Wednesday 28 February 
AB Dynamics PLCTrading Statement
ASA International Group PLCTrading Statement
Aston Martin Lagonda Global Holdings PLCFull Year Results
Avingtrans PLCHalf Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Derwent London PLCFull Year Results
Glenveagh Properties PLCFull Year Results
Grit Real Estate Income Group LtdHalf Year Results
Hutchmed China LtdFull Year Results
International Personal Finance PLCFull Year Results
Just Eat Takeaway.com NVFull Year Results
Primary Health Properties PLCFull Year Results
Reckitt Benckiser Group PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
RHI Magnesita NVFull Year Results
St James's Place PLCFull Year Results
Taylor Wimpey PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
7 Feb 2024 09:50

Hutchmed hails fruquintinib trial results for gastric cancer treatment

(Alliance News) - Hutchmed (China) Ltd on Wednesday said phase three data for fruquintinib in combination with paclitaxel showed an improvement in overall survival for patients with gastric or gastroesophageal junction adenocarcinoma.

Read more
2 Feb 2024 09:52

Hutchmed says Inmagene exercises option to licence drug candidates

(Alliance News) - Hutchmed (China) Ltd on Friday said Inmagene Biopharmaceuticals Ltd has exercised options to licence two drug candidates as part of a strategic partnership.

Read more
2 Feb 2024 09:42

Hutchmed partner Inmagene exercises options over two drug candidates

(Sharecast News) - Hutchmed China announced on Friday that Inmagene Biopharmaceuticals has exercised options to licence two drug candidates, IMG-007 and IMG-004, as part of their strategic partnership.

Read more
30 Jan 2024 10:32

Hutchmed's 'Elunate' approved under new Hong Kong rules

(Sharecast News) - Hutchmed China announced the approval of its drug 'Elunate', or fruquintinib, by the Pharmacy and Poisons Board of Hong Kong on Tuesday, for the treatment of adult patients with previously treated metastatic colorectal cancer (CRC).

Read more
30 Jan 2024 09:20

Hutchmed celebrates cancer drug approval in hometown of Hong Kong

(Alliance News) - Hutchmed (China) Ltd on Tuesday touted progress in Hong Kong, after its oral therapy for metastatic colorectal cancer received marketing approval in the city.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.